NCT03329950 2024-03-28A Study of CDX-1140 (CD40) as Monotherapy or in Combination in Patients With Advanced MalignanciesCelldex TherapeuticsPhase 1 Completed132 enrolled
NCT00002909 2013-02-05Phenylbutyrate in Treating Patients With Refractory Solid Tumors or LymphomaNational Cancer Institute (NCI)Phase 1 Completed24 enrolled